PANA Act of 2023

Bill 118 s 3159, also known as the PANA Act of 2023, is a piece of legislation currently being considered by the US Congress. The main purpose of this bill is to address issues related to public health and safety, specifically in the area of prescription drug pricing and access.

The PANA Act of 2023 aims to increase transparency in the pharmaceutical industry by requiring drug manufacturers to disclose information about the costs of producing and marketing their products. This information would then be made available to the public in order to help consumers make more informed decisions about their healthcare.

Additionally, the bill seeks to address the issue of high prescription drug prices by implementing measures to lower costs for consumers. This includes provisions to allow for the importation of cheaper prescription drugs from other countries and the establishment of a prescription drug affordability board to regulate drug prices. Furthermore, the PANA Act of 2023 includes provisions to improve access to healthcare services for underserved communities, such as increasing funding for community health centers and expanding Medicaid coverage. Overall, the PANA Act of 2023 is a comprehensive piece of legislation that aims to address key issues related to prescription drug pricing and access in order to improve public health and safety.